LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | R406 | 1.11 | uM | LJP6 | 0.8360 | 0.0258 | 0.7785 | 0.0330 |
| MDA-MB-231 | Pictilisib | 1.11 | uM | LJP6 | 0.7090 | 0.0250 | 0.6053 | 0.0373 |
| MDA-MB-231 | Gefitinib | 1.11 | uM | LJP6 | 1.0143 | 0.0371 | 1.0184 | 0.0498 |
| MDA-MB-231 | Geldanamycin | 1.11 | uM | LJP5 | 0.2420 | 0.0342 | -0.0275 | 0.0562 |
| MDA-MB-231 | Geldanamycin | 1.11 | uM | LJP6 | 0.2363 | 0.0543 | -0.0358 | 0.0834 |
| MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP5 | 0.5805 | 0.0716 | 0.4324 | 0.0953 |
| MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP6 | 0.6063 | 0.0984 | 0.4661 | 0.1352 |
| MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 0.9004 | 0.0142 | 0.8647 | 0.0204 |
| MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 0.2460 | 0.0270 | -0.0218 | 0.0456 |
| MDA-MB-231 | GSK 690693 | 1.11 | uM | LJP5 | 0.9511 | 0.0258 | 0.9343 | 0.0346 |
| MDA-MB-231 | GW843682X | 1.11 | uM | LJP6 | 0.2933 | 0.0295 | 0.0424 | 0.0467 |
| MDA-MB-231 | HG-5-113-01 | 1.11 | uM | LJP5 | 0.4735 | 0.0672 | 0.2860 | 0.0957 |
| MDA-MB-231 | HG-5-88-01 | 1.11 | uM | LJP6 | 0.8064 | 0.0628 | 0.7393 | 0.0822 |
| MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 0.9967 | 0.0407 | 0.9945 | 0.0548 |
| MDA-MB-231 | JNK-9L | 1.11 | uM | LJP6 | 0.2920 | 0.0506 | 0.0400 | 0.0776 |
| MDA-MB-231 | JW-7-24-1 | 1.11 | uM | LJP6 | 0.6664 | 0.0519 | 0.5485 | 0.0689 |
| MDA-MB-231 | Lapatinib | 1.11 | uM | LJP6 | 0.9459 | 0.0256 | 0.9260 | 0.0351 |
| MDA-MB-231 | LDN-193189 | 1.11 | uM | LJP5 | 0.7582 | 0.0267 | 0.6725 | 0.0363 |
| MDA-MB-231 | Linifanib | 1.11 | uM | LJP6 | 1.0641 | 0.0337 | 1.0866 | 0.0453 |
| MDA-MB-231 | Linsitinib | 1.11 | uM | LJP5 | 0.8798 | 0.0325 | 0.8371 | 0.0443 |
| MDA-MB-231 | Mitoxantrone | 1.11 | uM | LJP5 | 0.1664 | 0.0334 | -0.1298 | 0.0557 |
| MDA-MB-231 | Mitoxantrone | 1.11 | uM | LJP6 | 0.1625 | 0.0316 | -0.1350 | 0.0537 |
| MDA-MB-231 | MK2206 | 1.11 | uM | LJP6 | 0.8143 | 0.0257 | 0.7489 | 0.0332 |
| MDA-MB-231 | Neratinib | 1.11 | uM | LJP5 | 0.6473 | 0.1060 | 0.5222 | 0.1439 |
| MDA-MB-231 | Nilotinib | 1.11 | uM | LJP5 | 0.8328 | 0.0846 | 0.7755 | 0.1117 |